Zhang, T., Ouyang, H., Mei, X., Lu, B., Yu, Z., Chen, K., . . . Ji, L. (2019). Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2–NF-κB signaling pathway. FASEB J.

Zhang, Tianyu, Hao Ouyang, Xiyu Mei, Bin Lu, Zengyang Yu, Kaixian Chen, Zhengtao Wang, e Lili Ji. "Erianin Alleviates Diabetic Retinopathy By Reducing Retinal Inflammation Initiated By Microglial Cells Via Inhibiting Hyperglycemia-mediated ERK1/2–NF-κB Signaling Pathway." FASEB J 2019.

Zhang, Tianyu, et al. "Erianin Alleviates Diabetic Retinopathy By Reducing Retinal Inflammation Initiated By Microglial Cells Via Inhibiting Hyperglycemia-mediated ERK1/2–NF-κB Signaling Pathway." FASEB J 2019.